Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Mullen · SciRah

Researcher profile · Semantic Scholar

J. Mullen

Share profile

J. Mullen — researcher profile on SciRah

h-index: 17
Works: 37
Citations: 2,907

Most-cited papers

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
J. Calabrese, P. Keck, W. Macfadden, M. Minkwitz +6 more
2005American Journal of Psychiatry782 citations
Semantic Scholar
A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.
C. Bowden, H. Grunze, J. Mullen, M. Brecher +4 more
2005Journal of Clinical Psychiatry333 citations
Semantic Scholar
Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.
G. Sachs, K. Chengappa, T. Suppes, J. Mullen +3 more
2004Bipolar Disorders271 citations
Semantic Scholar
Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial.
R. McIntyre, M. Brecher, B. Paulsson, K. Huizar +1 more
2005European Neuropsychopharmacology234 citations
Semantic Scholar
The Eye As a Biomarker for Alzheimer's Disease
Jeremiah K. H. Lim, Qiao-Xin Li, Zheng He, A. Vingrys +5 more
2016Frontiers in Neuroscience196 citations Open access
Semantic Scholar
Quetiapine Versus Placebo in Combination With Lithium or Divalproex for the Treatment of Bipolar Mania
L. Yatham, B. Paulsson, J. Mullen, And Mårten Vågerö
2004Journal of Clinical Psychopharmacology181 citations
Semantic Scholar
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease
A. M. Wessels, P. Tariot, Jennifer A. Zimmer, Katherine J. Selzler +18 more
2019JAMA Neurology160 citations Open access
Semantic Scholar
A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study.
J. Mullen, M. Jibson, D. Sweitzer
2001Clinical Therapeutics151 citations
Semantic Scholar
Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies
E. Vieta, J. Mullen, M. Brecher, B. Paulsson +1 more
2005Current Medical Research and Opinion147 citations
Semantic Scholar
Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis.
M. Sajatovic, J. Mullen, D. Sweitzer
2002Journal of Clinical Psychiatry86 citations
Semantic Scholar
Quetiapine for the treatment of bipolar mania in older adults.
M. Sajatovic, J. Calabrese, J. Mullen
2008Bipolar Disorders72 citations
Semantic Scholar
Retinal Functional and Structural Changes in the 5xFAD Mouse Model of Alzheimer’s Disease
Jeremiah K. H. Lim, Qiao-Xin Li, Zheng He, A. Vingrys +4 more
2020Frontiers in Neuroscience63 citations Open access
Semantic Scholar
Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change.
A. Martínez-Àran, E. Vieta, K. R. Roy Chengappa, Samuel Gershon +2 more
2008Bipolar Disorders47 citations
Semantic Scholar
Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
N. Sussman, J. Mullen, B. Paulsson, M. Vågerö
2007Journal of Affective Disorders29 citations
Semantic Scholar
Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease
Jennifer A. Zimmer, S. Shcherbinin, M. Devous, S. Bragg +10 more
2021Alzheimer's & Dementia24 citations Open access
Semantic Scholar
What We Learn from the CTAD 2018 (Clinical Trials Alzheimer's Disease)
John R. Sims, Katherine J. Selzler, A. M. Downing, B. Willis +11 more
2018The journal of prevention of Alzheimer's disease22 citations Open access
Semantic Scholar
A Random-Assignment, Double-Blind, Clinical Trial of Once- vs Twice-Daily Administration of Quetiapine Fumarate in Patients with Schizophrenia or Schizoaffective Disorder: A Pilot Study
K. R. Roy Chengappa, H. Parepally, J. Brar, J. Mullen +2 more
2003Canadian journal of psychiatry. Revue canadienne de psychiatrie21 citations Open access
Semantic Scholar
Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
E. Vieta, J. Goldberg, J. Mullen, M. Vågerö +1 more
2007Journal of Affective Disorders16 citations
Semantic Scholar
A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone
J. Mintzer, J. Mullen, D. Sweitzer
2004Current Medical Research and Opinion16 citations
Semantic Scholar
Quetiapine vs placebo as adjunct to mood stabilizer for the treatment of acute mania
G. Sachs, J. Mullen, N. A. Devine, Dennis Sweitzer
200213 citations
Semantic Scholar
Clinical Bioavailability of the Novel BACE1 Inhibitor Lanabecestat (AZD3293): Assessment of Tablet Formulations Versus an Oral Solution and the Impact of Gastric pH on Pharmacokinetics
Nai-Dong Ye, S. Monk, Pankaj R. Daga, D. Bender +4 more
2018Clinical pharmacology in drug development12 citations Open access
Semantic Scholar
Population Pharmacokinetic Modeling With Enterohepatic Circulation for AZD3241 in Healthy Subjects and Patients With Multiple System Atrophy
Xiao Tong, Dian-Song Zhou, A. Savage, J. Mullen +5 more
2018Journal of clinical pharmacology11 citations
Semantic Scholar
P.2.140 A comparison of the efficacy and safety of quetiapine and risperidone
X. Zhong, D. Sweitzer, J. Russo, L. Potter +1 more
20037 citations
Semantic Scholar
Clinically Negligible Pharmacokinetic and Pharmacodynamic Interactions Between Lanabecestat and Dabigatran Etexilate, a Prototypical P‐gp Substrate
S. Monk, A. Kugler, Scott W. Andersen, Mosun A. Ayan-Oshodi +4 more
2019Journal of clinical pharmacology4 citations
Semantic Scholar
P.2.152 Double-blind, placebo-controlled study ofquetiapine in bipolar I depression
W. Macfadden, J. Calabrese, R. Mccoy, M. Minkwitz +2 more
20044 citations
Semantic Scholar
FOCUSED TOPIC SESSIONS FTS3-01 DISCUSSION OF BACE1 TRIAL FINDINGS: CHALLENGES AND OPPORTUNITIES FTS3-01-01 UMIBECESTAT (CNP520) IS NOT ASSOCIATEDWITH CHANGES IN HIPPOCAMPAL MORPHOLOGY IN RATS OR CHANGES IN CSFAD BIOMARKERS IN HUMANS TREATED FOR 3 MONTHS
V. Dubost, Katherine J. Selzler, A. Wessels, Scott W. Andersen +3 more
20192 citations
Semantic Scholar
FTS3-01-02: SUBGROUP POPULATIONS IN AMARANTH, A RANDOMIZED PHASE 2/3 STUDY IN EARLY ALZHEIMER'S DISEASE WITH LANABECESTAT
P. Tariot, Katherine J. Selzler, A. M. Wessels, S. Andersen +3 more
2019Alzheimer's & Dementia1 citations Open access
Semantic Scholar
FTS3-01-03: PERFORMANCE ON EXPLORATORY EFFICACY VARIABLES IN AMARANTH, A RANDOMIZED PHASE 2/3 STUDY IN EARLY ALZHEIMER'S DISEASE WITH LANABECESTAT
R. Stern, A. M. Wessels, Katherine J. Selzler, S. Andersen +2 more
2019Alzheimer's & Dementia1 citations Open access
Semantic Scholar
DT‐01‐04: LANABECESTAT: BASELINE CHARACTERISTICS OF PARTICIPANTS RANDOMIZED IN THE PHASE 2/3 AMARANTH STUDY
J. Sims, A. M. Downing, Scott W. Andersen, A. M. Wessels +9 more
20181 citations
Semantic Scholar
Random-assignment, double-blind, clinical trial of once- versus twice-daily administration of quetiapine in patients with schizophrenia or schizoaffective disorder
H. Parepally, Chen Kn, Jaspreet S. Brar, J. Mullen +2 more
20031 citations
Semantic Scholar
FTS3-01-03 PERFORMANCE ON EXPLORATORY EFFICACY VARIABLES IN AMARANTH, A RANDOMIZED PHASE 2/3 STUDY IN EARLYALZHEIMER’S DISEASE WITH LANABECESTAT FINAL EFFICACY, SAFETYAND BIOMARKER RESULTS OF THE PHASE 2B/3 RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED EARLY TRIAL OF ATABECESTAT IN PRECLINICAL ALZH
A. M. Wessels, Katherine J. Selzler, S. Andersen, J. Mullen +16 more
20190 citations
Semantic Scholar
P4‐210: LANABECESTAT: SCREENING PERFORMANCE FROM THE AMARANTH STUDY
A. M. Downing, A. Wessels, J. Zimmer, Laura E. Nickell +4 more
20180 citations
Semantic Scholar
Retinal structural and functional changes in mouse models of Alzheimer’s and Parkinson’s disease
Christine T. O. Nguyen, Jeremiah K. H. Lim, V. H. Wong, Bang V. Bui +3 more
20180 citations
Semantic Scholar
PMH74 COMPARING PSYCHOMETRIC PROPERTIES OF SELF-VERSUS INTERVIEWER-RATED INSTRUMENTS USED IN CLINICAL TRIALS FOR PATIENTS WITH ANXIETY DISORDERS
J. Mullen
20100 citations
Semantic Scholar
P.2.153 Double-blind,etiapine in bipolar depression
J. Calabrese, W. Macfadden, R. Mccoy, Margaret Minkwitz +2 more
20040 citations
Semantic Scholar
ERRATUM
L. Yatham, B. Paulsson, J. Mullen
20000 citations Open access
Semantic Scholar
Hypermedia and Educational Systems. Systems for Enhancing Medical Education: PSYCHE: An Object-Oriented Approach to Simulating Medical Education
J. Mullen
19900 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Paulsson×8
Invite
B. Paulsson — researcher profile on SciRah
A. M. Wessels×7
Invite
A. M. Wessels — researcher profile on SciRah
Katherine J. Selzler×7
Invite
Katherine J. Selzler — researcher profile on SciRah
J. Sims×7
Invite
J. Sims — researcher profile on SciRah

×5

Invite

D. Sweitzer — researcher profile on SciRah

Invite

S. Andersen — researcher profile on SciRah

A. M. Downing×5

Invite

A. M. Downing — researcher profile on SciRah

Scott W. Andersen×5

Invite

Scott W. Andersen — researcher profile on SciRah

J. Calabrese×4

Invite

J. Calabrese — researcher profile on SciRah

Invite

M. Brecher — researcher profile on SciRah

Jennifer A. Zimmer×4

Invite

Jennifer A. Zimmer — researcher profile on SciRah

Invite

J. Zimmer — researcher profile on SciRah